Hydrogen chloride-ethyl acetate → 1-(3-Ethyl-5-methylpyridin-2-yl)piperazine hydrochloride
Reaction equation
C(OC([N:8]1[CH2:13][CH2:12][N:11]([C:14]2[C:19]([Cl:20])=[CH:18][C:17]([CH3:21])=[CH:16][N:15]=2)[CH2:10][CH2:9]1)=O)(C)(C)C.Cl.[C:23](OCC)(=O)[CH3:24]>>[ClH:20].[CH2:23]([C:19]1[C:14]([N:11]2[CH2:10][CH2:9][NH:8][CH2:13][CH2:12]2)=[N:15][CH:16]=[C:17]([CH3:21])[CH:18]=1)[CH3:24]Participants
3
Procedure
By reaction and treatment in the same manner as in Example 53 and using 4-(3-chloro-5-methylpyridin-2-yl)piperazine-1-carboxylic acid tert-butyl ester (9 g), which is the intermediate described in Preparation Example 48, a compound was obtained, which was treated with 4N hydrogen chloride/ethyl acetate (2 mL) to give the title compound (1.1 g).
Workup
- customBy reaction and treatment in the same manner as in Example 53
- customdescribed in Preparation Example 48
- customa compound was obtained
Sources & evidence
- ORD record
- ord-5267de9e4ea840cf9ef849d61528ebb0
- Source dataset
- uspto-grants-2013_01
- Patent number
- US08354401B2
Reaction notes
Loading…